enVVeno Medical (NVNO) Capital Expenditures (2017 - 2024)

enVVeno Medical's Capital Expenditures history runs 8 years deep, the most recent figure standing at $4000.0 for Q4 2024.

• In Q4 2024, Capital Expenditures changed 0.0% year-over-year to $4000.0; the TTM figure through Dec 2025 stood at $13000.0 (down 64.86% YoY), while the FY2025 annual figure was $5000.0, down 86.49% from the prior year.
• Capital Expenditures was $4000.0 for Q4 2024 at enVVeno Medical, down from $9000.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $152000.0 in Q3 2021 to a low of $3000.0 in Q3 2023.
• Historically, Capital Expenditures has averaged $36664.6 across 5 years, with a median of $17500.0 in 2022.
• The sharpest annual moves came in 2021 and 2023: Capital Expenditures soared 508.85% in 2021, then slumped 92.75% in 2023.
• A 5-year view of Capital Expenditures shows it stood at $27540.0 in 2020, then surged by 136.02% to $65000.0 in 2021, then plunged by 86.15% to $9000.0 in 2022, then tumbled by 55.56% to $4000.0 in 2023, then changed by 0.0% to $4000.0 in 2024.
• The last three Capital Expenditures figures came in at $4000.0 (Q4 2024), $9000.0 (Q3 2024), and $14000.0 (Q2 2024), per Business Quant data.